Immunovant, Inc. (IMVT) Earnings
NASDAQ·Healthcare·Biotechnology
$28.87
+2.52%
Mkt Cap $5.87B
EPS — Estimate vs Actual
Mkt Cap
$5.87B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78
NASDAQ·Healthcare·Biotechnology
$28.87
+2.52%
Mkt Cap $5.87B
Mkt Cap
$5.87B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.78